Gerhard A Zielhuis

A generalized concept of power helped to choose optimal endpoints in clinical trials.

George F Borm, Gert J van der Wilt, Jan A M Kremer, 2007, Journal of clinical epidemiology.

The FAIR guiding principles for data stewardship: fair enough?

Annelien L Bredenoord, Gerhard A Zielhuis, Martin Boeckhout, 2018, European Journal of Human Genetics.

Definitions of exacerbations: does it really matter in clinical trials on COPD?

Dirkje S Postma, Gerhard A Zielhuis, Emiel F M Wouters, 2009, Chest.

Prediction of asthma in young adults using childhood characteristics: Development of a prediction rule.

Maroeska M Rovers, Gerhard A Zielhuis, A. Schilder, 2006, Journal of clinical epidemiology.

Publication bias was not a good reason to discourage trials with low power.

George F Borm, Gerhard A Zielhuis, Martin den Heijer, 2009, Journal of clinical epidemiology.

New evidence of the influence of exogenous and endogenous factors on sperm count in man.

Gerhard A Zielhuis, G. Zielhuis, W. Y. Wong, 2003, European journal of obstetrics, gynecology, and reproductive biology.

Teratogenic mechanisms of medical drugs.

Gerhard A Zielhuis, Nel Roeleveld, I. V. van Rooij, 2010, Human reproduction update.

Otitis media

Maroeska M Rovers, Richard M Rosenfeld, Gerhard A Zielhuis, 2004, The Lancet.